Literature DB >> 21555166

Synthesis and evaluation of monoamidoxime derivatives: toward new antileishmanial compounds.

Lucie Paloque1, Ahlem Bouhlel, Christophe Curti, Aurélien Dumètre, Pierre Verhaeghe, Nadine Azas, Patrice Vanelle.   

Abstract

A new series of monoamidoxime derivatives was synthesized using manganese(III) acetate by microwave irradiation. Several amidoximes (27-31, 33, 38) showed valuable in vitro activities toward Leishmania donovani promastigotes, exhibiting IC(50) values between 5.21 and 7.89 μM. In parallel, the cytotoxicity of these compounds was evaluated on murine J774A.1 cells, revealing the corresponding selectivity index (SI). Among the 13 tested compounds, 4 monoamidoximes (27-30) exhibited an SI more than 20 times better than pentamidine. Moreover, monoamidoxime 28 (4-[5-Benzyl-3-(4-fluorophenylsulfonyl)-5-methyl-4,5-dihydrofuran-2-yl]-N'-hydroxybenzimidamide) is 40 times more selective than pentamidine, and 1.6 times more than amphotericin B, used as reference drug compounds.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21555166     DOI: 10.1016/j.ejmech.2011.04.026

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  New methodology for the synthesis of thiobarbiturates mediated by manganese(III) acetate.

Authors:  Ahlem Bouhlel; Christophe Curti; Patrice Vanelle
Journal:  Molecules       Date:  2012-04-10       Impact factor: 4.411

Review 2.  MAOS and medicinal chemistry: some important examples from the last years.

Authors:  Nailton M Nascimento-Júnior; Arthur E Kümmerle; Eliezer J Barreiro; Carlos A M Fraga
Journal:  Molecules       Date:  2011-11-07       Impact factor: 4.411

3.  Manganese(III) acetate-mediated oxidative cyclization of a-methylstyrene and trans-stilbene with b-ketosulfones.

Authors:  Ahlem Bouhlel; Christophe Curti; Clémence Tabelé; Patrice Vanelle
Journal:  Molecules       Date:  2013-04-11       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.